Perturbations in the gut microbiome of C57BL/6 mice by the sobriety aid Antabuse® (disulfiram)
Journal of Applied Microbiology · 2025
DOI: 10.1093/jambio/lxae305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2025. Verfasst von Sarah E Evans und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, United States. Hauptthemen laut MEDLINE: Mice, Inbred C57BL, Gastrointestinal Microbiome, Feces, Disulfiram. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Aims
Disulfiram (Antabuse®) is an oral alcohol sobriety medication that exhibits antimicrobial activity against Gram-positive facultative anaerobes. The aims of this study were to measure the antimicrobial activity against anaerobic bacteria of the gut human microbiome and establish the extent that disulfiram alters the microbial composition of the ileum, cecum, and feces using C57BL/6 mice. Methods and results Antimicrobial susceptibility testing by the microdilution method revealed that disulfiram inhibits the in vitro growth of gut anaerobic species of Bacteroides, Clostridium, Peptostreptococcus, and Porphyromonas. Differential sequencing of 16S rRNA isolated from the ileum, cecum, and feces contents of treated vs. untreated mice showed that disulfiram enriches the Gram-negative enteric population. In female mice, the enrichment was greatest in the ileum, whereas the feces composition in male mice was the most heavily altered.
Conclusions
Daily administration of oral disulfiram depletes the enteric Gram-positive anaerobe population as predicted by the minimum inhibitory concentration data for isolates from the human gut microbiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, United States.
- Department of Pharmaceutical Sciences, School of Pharmacy, Marshall University, Huntington, WV 25755, United States.
- Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States.
ORCID-Profile: Timothy E Long
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- National Institutes of Health
Zitieren
APA
Evans, S. E., Valentine, M. E., Gallimore, F., Meka, Y., Koehler, S. I., Yu, H. D., Valentovic, M. A., & Long, T. E. (2025). Perturbations in the gut microbiome of C57BL/6 mice by the sobriety aid Antabuse® (disulfiram). Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae305
Vancouver
Evans SE, Valentine ME, Gallimore F, Meka Y, Koehler SI, Yu HD, et al. Perturbations in the gut microbiome of C57BL/6 mice by the sobriety aid Antabuse® (disulfiram). Journal of Applied Microbiology. 2025. doi:10.1093/jambio/lxae305
BibTeX
@article{Evans2025,
author = {Evans, Sarah E and Valentine, Meagan E and Gallimore, Fallon and Meka, Yogesh and Koehler, Samuel I and Yu, Hongwei D and Valentovic, Monica A and Long, Timothy E},
title = {Perturbations in the gut microbiome of C57BL/6 mice by the sobriety aid Antabuse® (disulfiram)},
journal = {Journal of Applied Microbiology},
year = {2025},
doi = {10.1093/jambio/lxae305}
}
EUVIMED